Filing Flows

Filing Flows › Stryker (SYK) › Recalls, complaints & regulation

Stryker (SYK): recalls, EPA violations and clinical trials

Stryker (SYK) beyond its filings: 58 recalls in the last 12 months (211 in five years, 0 Class I); 2 EPA-regulated facilities in violation, no penalties in five years; 28 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
STRYKER AVIATIONPortage, MIViolation Identified—
STRYKER STPStryker, OHViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Stryker's latest quarter

Stryker, Q3 2026: revenue $6.5B (+8% year over year), operating margin 15.9%, net earnings $753M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.

Questions

Has Stryker had any recalls?

211 recalls on file over five years from the FDA, CPSC and NHTSA; 58 in the last 12 months.

Has Stryker been fined by the EPA?

The 38 EPA-regulated facilities on file under its name drew no penalties in five years; 2 are in violation now.

How many clinical trials does Stryker have?

28 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.